217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose

CVX Vaccination Code


CVX code217
short nameCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
full nameSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
statusInactive
notesOriginal monovalent Pfizer tris-sucrose formulation FDA EUA (12+ yrs) and BLA (16+ yrs), FDA rescinded monovalent use 08/31/2022, BLA NDCs not retired until 09/11/2023.
vaccineyes
updated2023-11-02
groups
codenamestatus
213COVID-19Inactive
ICD-10-CMZ23  Encounter for immunization
cpt® codes
codedescrupdated
91305Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
  note  COVID-19 Vaccine - EUA authorized for primary series and IC, EUA rescinded 8/31/202 for monovalent boosters		2024-01-11
documents
editionstatusnamepdf link
2022-12-08HistoricCOVID-19 Pfizer BioNTech EUA Recipient-Caregiver Fact Sheet-12 years and older
demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.